Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics-Reference-Cited by-同舟云学术

Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics

Published:2011-12-16 Issue:1 Volume:1 Page:11-19
ISSN:2155-6660
Container-title:Journal of Drug Assessment
language:en
Short-container-title:Journal of Drug Assessment

Author:

Fitzpatrick Lorraine A.,Bilezikian John P.,Wooddell Margaret,Paul Gitanjali,Kolatkar Nikheel S.,Nino Antonio J.,Miller Colin G.,Bogado Cesar E.,Arnaud Claude D.,Cobitz Alexander R.

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference20 articles.

1. Risk of Fracture in Women with Type 2 Diabetes: the Women’s Health Initiative Observational Study

2. Bone mineral density in patients with type 1 and type 2 diabetes.

3. Sex Differences in Osteoporosis in Older Adults With Non—Insulin-Dependent Diabetes Mellitus

4. Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The forgotten type 2 diabetes mellitus medicine: rosiglitazone;Diabetology International;2021-06-29

2. Metformin monotherapy for adults with type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2020-06-05

3. Evaluation of Quantitative Computed Tomography Cortical Hip Quadrant in a Clinical Trial With Rosiglitazone: A Potential New Study Endpoint;Journal of Clinical Densitometry;2016-10

4. Effects of Rosiglitazone vs Metformin on Circulating Osteoclast and Osteogenic Precursor Cells in Postmenopausal Women with Type 2 Diabetes Mellitus;The Journal of Clinical Endocrinology & Metabolism;2014-10

5. Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus;The Journal of Clinical Endocrinology & Metabolism;2013-04-01